Angela Chou

Clinical Associate Professor Angela Chou is affiliated with the University of Sydney's Northern Clinical School and the Kolling Institute. She holds dual roles as a surgical pathologist at Royal North Shore Hospital and a translational researcher specializing in gastrointestinal cancers, endocrine tumors, and renal transplant pathology. Her research focuses on cancer genomics, molecular diagnostics, and improving clinical outcomes through precision medicine. Chou earned her PhD in 2017 from UNSW and completed a postdoctoral fellowship at the Garvan Institute, contributing to the Australian Pancreatic Genome Initiative (APGI).

Education: PhD (UNSW, 2017), Postdoctoral Fellowship (Garvan Institute, 2020), RCPA Fellowship (2010). She worked part-time at St Vincent's Hospital while completing her pancreatic cancer research.

Research interests include biomarker discovery, cancer genomics, renal transplantation pathology, and molecular diagnostics. She collaborates internationally, notably with the International Study Group on Non-Pancreatic Periampullary Cancer (PERIPAN 2023).

Her 15 most recent articles (2020–2025) emphasize AI-driven pathology, tumor grading systems, and genomic profiling in cancers like pancreatoblastoma and medullary thyroid carcinoma. Key themes include prognostic nomograms, tumor-infiltrating lymphocytes, and therapeutic biomarker development.

• Received 12+ awards, including the 2020 Cancer Institute NSW Early Career Award and multiple Wild Fire Group Awards.
• Editorial roles: Associated editor for Pathology (RCPA journal).
• Leadership: Member of AGITG Translational Research Committee and Sydney Thyroid Cancer Research Group.

Labs/Teams: Kolling Institute Cancer Diagnosis & Pathology Group; collaborates with RNSH renal transplant teams and international consortia like ISGPP.